| MKDVX | VIVIX | MKDVX / VIVIX | |
| Total Expense Ratio | 0.59 | 0.03 | 1,967% |
| Annual Report Gross Expense Ratio | 0.59 | 0.03 | 1,967% |
| Fund Existence | 10 years | 28 years | - |
| Gain YTD | 11.295 | 13.676 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 5000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 20.2B | 245B | 8% |
| Annual Yield % from dividends | 1.95 | 1.87 | 104% |
| Returns for 1 year | 16.71 | 25.35 | 66% |
| Returns for 3 years | 28.19 | 52.95 | 53% |
| Returns for 5 years | 7.14 | 56.89 | 13% |
| Returns for 10 years | 31.96 | 160.54 | 20% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MLAIX | 12.14 | 0.44 | +3.76% |
| NYLI Winslow Large Cap Growth Class I | |||
| FMCCX | 55.73 | N/A | N/A |
| Fidelity Advisor Stock Selec Mid Cp I | |||
| GREIX | 9.97 | N/A | N/A |
| Goldman Sachs Real Estate Securities Ins | |||
| ITGRX | 43.88 | N/A | N/A |
| Nomura Global Growth Fund Class R6 | |||
| SVXCX | 86.34 | N/A | N/A |
| Smead International Value C | |||